P408: COMBINATORIAL BCL-2 FAMILY EXPRESSION IN ACUTE MYELOID LEUKEMIA STEM CELLS PREDICTS CLINICAL RESPONSE TO AZACITIDINE/VENETOCLAX

• Simon Renders,
• Alexander Waclawiczek,
• Aino-Maija Leppä,
• Karolin Stumpf,
• Barbara Betz,
• Cecilia Reyneri,
• Elisa Donato,
• Maike Janssen,
• Julia Unglaub,
• Rabia Shahswar,
• Simon Raffel,
• Michael Hundemer,
• Michael Heuser,
• Carsten Müller-Tidow,
• Tim Sauer,
• Andreas Trumpp

Affiliations

Simon Renders

1 Heidelberg University hospital, Department of Internal Medicine V, Hematology, Oncology and Rheumatology

Alexander Waclawiczek

2 Division of Stem Cells and Cancer, German Cancer Research Center (DKFZ) and Heidelberg Institute for Stem Cell Technology and Experimental Medicine (HI-STEM gGmbH), Heideberg, Germany

Aino-Maija Leppä

2 Division of Stem Cells and Cancer, German Cancer Research Center (DKFZ) and Heidelberg Institute for Stem Cell Technology and Experimental Medicine (HI-STEM gGmbH), Heideberg, Germany

Karolin Stumpf

2 Division of Stem Cells and Cancer, German Cancer Research Center (DKFZ) and Heidelberg Institute for Stem Cell Technology and Experimental Medicine (HI-STEM gGmbH), Heideberg, Germany

Barbara Betz

2 Division of Stem Cells and Cancer, German Cancer Research Center (DKFZ) and Heidelberg Institute for Stem Cell Technology and Experimental Medicine (HI-STEM gGmbH), Heideberg, Germany

Cecilia Reyneri

2 Division of Stem Cells and Cancer, German Cancer Research Center (DKFZ) and Heidelberg Institute for Stem Cell Technology and Experimental Medicine (HI-STEM gGmbH), Heideberg, Germany

Elisa Donato

2 Division of Stem Cells and Cancer, German Cancer Research Center (DKFZ) and Heidelberg Institute for Stem Cell Technology and Experimental Medicine (HI-STEM gGmbH), Heideberg, Germany

Maike Janssen

1 Heidelberg University hospital, Department of Internal Medicine V, Hematology, Oncology and Rheumatology

Julia Unglaub

1 Heidelberg University hospital, Department of Internal Medicine V, Hematology, Oncology and Rheumatology

Rabia Shahswar

3 Department of Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School

Simon Raffel

1 Heidelberg University hospital, Department of Internal Medicine V, Hematology, Oncology and Rheumatology

Michael Hundemer

1 Heidelberg University hospital, Department of Internal Medicine V, Hematology, Oncology and Rheumatology

Michael Heuser

3 Department of Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School

Carsten Müller-Tidow

1 Heidelberg University hospital, Department of Internal Medicine V, Hematology, Oncology and Rheumatology

Tim Sauer

1 Heidelberg University hospital, Department of Internal Medicine V, Hematology, Oncology and Rheumatology

Andreas Trumpp

2 Division of Stem Cells and Cancer, German Cancer Research Center (DKFZ) and Heidelberg Institute for Stem Cell Technology and Experimental Medicine (HI-STEM gGmbH), Heideberg, Germany